1-8 of 8
Sunil Badve
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer

Milan Radovich, Jeffrey P. Solzak, Chao J. Wang, Bradley A. Hancock, Sunil Badve, Sandra K. Althouse, Steven M. Bray, Anna Maria V. Storniolo, Tarah J. Ballinger, Bryan P. Schneider, Kathy D. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3235–3241.
https://doi.org/10.1158/1078-0432.CCR-21-3078
Published: 02 August 2022
View article titled, Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer
Open the PDF for Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, Paraic A. Kenny, George W. Sledge, Jr, Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7194–7203.
https://doi.org/10.1158/1078-0432.CCR-10-3357
Published: 14 November 2011
View article titled, Relationship between Quantitative <em>GRB7</em> RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer
Open the PDF for Relationship between Quantitative <em>GRB7</em> RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model

Ranjana Mitra, Jinseon Lee, Jisuk Jo, Monica Milani, Jeanette N. McClintick, Howard J. Edenberg, Kenneth A. Kesler, Karen M. Rieger, Sunil Badve, Oscar W. Cummings, Ahmed Mohiuddin, Dafydd G. Thomas, Xianghua Luo, Beth E. Juliar, Lang Li, Clementina Mesaros, Ian A. Blair, Anjaiah Srirangam, Robert A. Kratzke, Clement J. McDonald, Jhingook Kim, David A. Potter
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (9): 2934–2946.
https://doi.org/10.1158/1078-0432.CCR-10-1803
Published: 01 May 2011
View article titled, Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model
Open the PDF for Prediction of Postoperative Recurrence-Free Survival in Non–Small Cell Lung Cancer by Using an Internationally Validated Gene Expression Model in another window
Includes: Supplementary data
Journal Articles

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer

Joseph A. Sparano, Lori J. Goldstein, Barrett H. Childs, Steven Shak, Diana Brassard, Sunil Badve, Frederick L. Baehner, Roberto Bugarini, Steve Rowley, Edith Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson, George W. Sledge, Jr., Robert Gray
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (24): 7693–7700.
https://doi.org/10.1158/1078-0432.CCR-09-1450
Published: 14 December 2009
View article titled, Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Open the PDF for Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Sunil Badve, Dmitry Turbin, Mangesh A. Thorat, Akira Morimiya, Torsten O. Nielsen, Charles M. Perou, Sandi Dunn, David G. Huntsman, Harikrishna Nakshatri
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4415–4421.
https://doi.org/10.1158/1078-0432.CCR-07-0122
Published: 01 August 2007
View article titled, FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival
Open the PDF for FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival in another window
Journal Articles

Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer

Amelia E. Hochreiter, Hongling Xiao, Erin M. Goldblatt, Sergei M. Gryaznov, Kathy D. Miller, Sunil Badve, George W. Sledge, Brittney-Shea Herbert
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (10): 3184–3192.
https://doi.org/10.1158/1078-0432.CCR-05-2760
Published: 17 May 2006
View article titled, Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer
Open the PDF for Telomerase Template Antagonist GRN163L Disrupts Telomere Maintenance, Tumor Growth, and Metastasis of Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer

Anjaiah Srirangam, Ranjana Mitra, Mu Wang, J. Christopher Gorski, Sunil Badve, LeeAnn Baldridge, Justin Hamilton, Hiromitsu Kishimoto, John Hawes, Lang Li, Christie M. Orschell, Edward F. Srour, Janice S. Blum, David Donner, George W. Sledge, Harikrishna Nakshatri, David A. Potter
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1883–1896.
https://doi.org/10.1158/1078-0432.CCR-05-1167
Published: 21 March 2006
View article titled, Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer
Open the PDF for Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer in another window
Journal Articles

A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171

Kathy D. Miller, Michael Miller, Sanjana Mehrotra, Beamon Agarwal, Bruce H. Mock, Qi-Huang Zheng, Sunil Badve, Gary D. Hutchins, George W. Sledge, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 281–288.
https://doi.org/10.1158/1078-0432.CCR-05-0219
Published: 05 January 2006
View article titled, A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171
Open the PDF for A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171 in another window